Evidence map›Paper›PMID 22915123›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.

Bénédicte Oulès, Dolores Del Prete, Barbara Greco, Xuexin Zhang, Inger Lauritzen, Jean Sevalle, Sebastien Moreno, Patrizia Paterlini-Bréchot, Mohamed Trebak, Frédéric Checler and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed, 233 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Neuronal Calcium Signaling and Cytoskeletal Dynamics in Neurodegeneration.International journal of molecular sciences · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Bénédicte OulèsInstitut National de la Santé et de la Recherche Médicale U807 and Paris V University, Paris F-75015, France.
Dolores Del Prete
Barbara Greco
Xuexin Zhang
Inger Lauritzen
Jean Sevalle
Sebastien Moreno
Patrizia Paterlini-Bréchot
Mohamed Trebak
Frédéric Checler
Fabio Benfenati
Mounia Chami
Fondation pour la Recherche Médicale · FRAlbany Medical Center Hospital · USCentre National de la Recherche Scientifique · FRItalian Institute of Technology · ITInserm · FRInstitut National de Recherche en Santé Publique · MLUniversité Côte d'Azur · FR

Funding

Receptor-regulated Ca2+ Entry Pathways in Smooth MuscleR01HL097111 · NHLBI · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI TREBAK, MOHAMED · 2010 to 2019
$3.7M
NHLBI NIH HHS 5R01HL097111NHLBI NIH HHS R01 HL097111
6 · The paper itself

Abstract

In Alzheimer disease (AD), the perturbation of the endoplasmic reticulum (ER) calcium (Ca²⁺) homeostasis has been linked to presenilins, the catalytic core in γ-secretase complexes cleaving the amyloid precursor protein (APP), thereby generating amyloid-β (Aβ) peptides. Here we investigate whether APP contributes to ER Ca²⁺ homeostasis and whether ER Ca²⁺ could in turn influence Aβ production. We show that overexpression of wild-type human APP (APP(695)), or APP harboring the Swedish double mutation (APP(swe)) triggers increased ryanodine receptor (RyR) expression and enhances RyR-mediated ER Ca²⁺ release in SH-SY5Y neuroblastoma cells and in APP(swe)-expressing (Tg2576) mice. Interestingly, dantrolene-induced lowering of RyR-mediated Ca²⁺ release leads to the reduction of both intracellular and extracellular Aβ load in neuroblastoma cells as well as in primary cultured neurons derived from Tg2576 mice. This Aβ reduction can be accounted for by decreased Thr-668-dependent APP phosphorylation and β- and γ-secretases activities. Importantly, dantrolene diminishes Aβ load, reduces Aβ-related histological lesions, and slows down learning and memory deficits in Tg2576 mice. Overall, our data document a key role of RyR in Aβ production and learning and memory performances, and delineate RyR-mediated control of Ca²⁺ homeostasis as a physiological paradigm that could be targeted for innovative therapeutic approaches.

Indexed as

Alzheimer DiseaseAminophenolsAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesAnalysis of VarianceAnimalsBrainCaffeineCalciumCalcium Channel BlockersCells, CulturedCytosolDantroleneDisease Models, AnimalEmbryo, Mammalian3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dioneAminophenolsAmyloid beta-PeptidesAmyloid beta-Protein Precursoramyloid beta-protein precursor C-terminal fragment beta, humanAmyloid Precursor Protein SecretasesCaffeineCalciumCalcium Channel BlockersDantroleneEnzyme InhibitorsInositol 1,4,5-Trisphosphate ReceptorsMaleimidesMembrane ProteinsMuscle Relaxants, CentralNerve Tissue ProteinsPeptide FragmentsPurinesRNA, MessengerRoscovitineRyanodine Receptor Calcium Release Channel

Identifiers

PMID22915123
PMCPMC3458216
OpenAlexW1970049338

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.